Join
Live feed
·
PRReleasevia Quantisnow
Oncocyte Corporation logo

Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K

ByQuantisnow·Wall Street's wire, on your screen.
OCX· Oncocyte Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.